The European Society for ME (ESME) is pleased to welcome Dr. Jonathan Kerr as an honorary member. Dr. Kerr is a much respected ME/CFS researcher. He has participated in many ME/CFS conferences, where he has presented important findings,especially concerning genomic subtypes in ME/CFS patients. 

He currently works at St. George’s University in London where he and his team are examining the role of XRMV in modulaton of NK cell cytotoxicity and NK cell gene abnormalities in ME/CFS patients and normal blood donors.

He is also collaborating with the Whittemore Peterson Institute in a study to develop diagnostic biomarkers in order to predict response to immune modulating therapy and vaccines.

In the past, Dr. Kerr has collaborated with The CFS Research Foundation and published important papers about Parvo B19 in ME/CFS, as well as groundbreaking work in genomic subtypes. See the list of publications here: http://www.cfsrf.com/Publications.htm 

Dr. Kerr is also a member of the American-based International Association of CFS/ME.

ESME is proud to have Dr. Kerr on board because he personifies the spirit of openness and cooperation between scientists that ESME is striving for. Thank you Dr. Kerr for believing in us and for the important ME/CFS research you do.

To read about more of Dr. Kerr’s research, please follow these links:

NIH Bets $1.6 Million on Continued ME/CFS Research by Drs. Mikovits & Kerr
October 21, 2009
www.prohealth.com/library/showarticle.cfm

Enterovirus infection of the stomach in chronic fatigue syndrome/myalgic encephalomyelitis

jcp.bmjjournals.com/content/61/1/1.full

 Seven genomic subtypes of Chronic Fatigue Syndrome / Myalgic Encephalomyelitis (CFS/ME): a detailed analysis of gene networks and clinical  phenotypes 

www.cfids-cab.org/rc/Kerr-3a.pdf
 
Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with Chronic Fatigue Syndrome / Myalgic Encephalomyelitis vir.sgmjournals.org/cgi/content/abstract/vir.0.017590-0v1